Analytical Data
-
Gene name
SPANXC
- Application
-
Alternative Names
SPANXC;KIAA0437;SET-binding Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NY87
-
Expression Region
1-97aa
-
AA Sequence
MDKQSSAGGV KRSVPCESNE VNETMPETPT GDSDPQPAPK KMKTSESSTI LVVRYRRNVK RTSPEELLND HARENRINPL QMEEEEFMEI MVEIPAK
-
Molecular Weight
10.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPANXC is a member of the SPAN family of proteins, which are known for their roles in tumorigenesis and immune response. This protein has gained attention due to its differential expression in various cancer types, making it a potential biomarker for tumor diagnosis and prognosis. Research has indicated that SPANXC is involved in important cellular processes, including cell proliferation and apoptosis, highlighting its significance in cancer biology. The study of SPANXC recombinant proteins aims to elucidate its functional properties and interactions within the tumor microenvironment. By generating and studying these recombinant proteins, researchers seek to better understand the molecular mechanisms underlying SPANXC's involvement in cancer development, potentially paving the way for novel therapeutic strategies. Additionally, SPANXC's immunogenicity presents opportunities for developing targeted cancer immunotherapies. Overall, the exploration of SPANXC recombinant proteins is a promising avenue for advancing our knowledge of cancer biology and improving patient outcomes.











